Several genetic and pharmacologic approaches were used to determine how leptin regulates Notch (ligands/receptors/targets) and the impact of Notch signaling on leptin-induced VEGF/VEGFR-2 expression in breast cancer cells. The gene discussed is LEP; the disease is breast cancer.